Quek Samuel Y P, Gomes-Zagury Julyana, Subramanian Gayathri
Professor, Rutgers School of Dental Medicine, Department of Diagnostic Sciences, Division of Oral Medicine, Rutgers School of Dental Medicine, Newark, New Jersey.
Adjunct Professor, Rutgers School of Dental Medicine, Department of Diagnostic Sciences, Division of Orofacial Pain, Newark, New Jersey.
Anesth Prog. 2020 Jun 1;67(2):103-106. doi: 10.2344/anpr-67-01-03.
The twin block, introduced in 2014, has proven to be more advantageous for the management of myogenous orofacial pain than the masseteric nerve block, which was introduced in 2009. The twin block is an extraoral nerve block injection which passes through the temporal fossa to anesthetize both the masseteric and the deep temporal nerves as they exit the infratemporal fossa at the infratemporal crest. Similar to the masseteric nerve block, the twin block has demonstrated efficacy with expeditious and sustained relief of myogenous face pain originating from the masseter muscle. Furthermore, in a 6-month prospective treatment study, that has been accepted for publication, the twin block has been demonstrated as comparable to trigger point injections in the management of chronic myofascial pain of masseteric origin. The twin block's ability to mitigate myogenous pain from both the masseter and temporalis muscles and its ease of administration are the key advantages over the masseteric nerve block. Since its inception, we have refined the technique for administering the twin block and our clinical experience corroborates its safety and efficacy. This review describes the refined technique and its safety in the context of the region's applied anatomy.
2014年引入的双阻滞已被证明在治疗肌源性口面部疼痛方面比2009年引入的咬肌神经阻滞更具优势。双阻滞是一种口外神经阻滞注射,它穿过颞窝,在咬肌神经和颞深神经穿出颞下窝到达颞下嵴时对其进行麻醉。与咬肌神经阻滞类似,双阻滞已证明对源自咬肌的肌源性面部疼痛有迅速且持续的缓解效果。此外,在一项已被接受发表的为期6个月的前瞻性治疗研究中,双阻滞在治疗咬肌源性慢性肌筋膜疼痛方面已被证明与触发点注射相当。双阻滞减轻咬肌和颞肌肌源性疼痛的能力及其易于实施是相对于咬肌神经阻滞的关键优势。自其问世以来,我们已改进了双阻滞的给药技术,我们的临床经验证实了其安全性和有效性。本综述在该区域应用解剖学的背景下描述了改进技术及其安全性。